These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 1922487)
21. Alzheimer's disease: how to give and monitor tacrine therapy. Woo JK; Lantz MS Geriatrics; 1995 May; 50(5):50-3. PubMed ID: 7737527 [TBL] [Abstract][Full Text] [Related]
22. Effect of tacrine in Alzheimer's disease: or non-effect? Broe GA; Creasey H Med J Aust; 1994 Sep; 161(6):348-9. PubMed ID: 8090107 [No Abstract] [Full Text] [Related]
23. Tacrine in Alzheimer's disease. Lachs M N Engl J Med; 1993 Mar; 328(11):809-10. PubMed ID: 8437606 [No Abstract] [Full Text] [Related]
24. Effectiveness and safety of velnacrine for the treatment of Alzheimer's disease. A double-blind, placebo-controlled study. Mentane Study Group. Antuono PG Arch Intern Med; 1995 Sep; 155(16):1766-72. PubMed ID: 7654110 [TBL] [Abstract][Full Text] [Related]
25. Tacrine for Alzheimer's disease. Kelly BT Am Fam Physician; 1995 Sep; 52(3):779. PubMed ID: 7653420 [No Abstract] [Full Text] [Related]
27. Tacrine for Alzheimer's disease: why is it not available on prescription to UK sufferers? Wilcock G Age Ageing; 1994 Sep; 23(5):353-5. PubMed ID: 7825478 [No Abstract] [Full Text] [Related]
28. Maximizing function in Alzheimer's disease: what role for tacrine? Smucker WD Am Fam Physician; 1996 Aug; 54(2):645-52. PubMed ID: 8701842 [TBL] [Abstract][Full Text] [Related]
29. Tacrine and lecithin in Alzheimer's disease. Serum tacrine concentrations too low. Roberts C; Mäkelä P; Ford J; Truman C BMJ; 1994 Jun; 308(6942):1506; author reply 1507. PubMed ID: 8019289 [No Abstract] [Full Text] [Related]
30. [Tacrine]. Dávila C; Viteri C; de Castro P Rev Med Univ Navarra; 1997; 41(1):58-64. PubMed ID: 9527715 [TBL] [Abstract][Full Text] [Related]
31. [Convulsive crisis as a possible adverse reaction to the treatment with tacrine in Alzheimer's disease]. García-Díaz JD; Fraguas C; Garcimartín C Med Clin (Barc); 1998 Sep; 111(7):279. PubMed ID: 9789247 [No Abstract] [Full Text] [Related]
32. A review of the randomized controlled trials of tacrine in the treatment of Alzheimer's disease: methodologic considerations. Conway EL Clin Neuropharmacol; 1998; 21(1):8-17. PubMed ID: 9579280 [TBL] [Abstract][Full Text] [Related]
33. Advances in the treatment of Alzheimer's disease. Schneider LS Aging (Milano); 1998 Apr; 10(2):156-7. PubMed ID: 9666210 [No Abstract] [Full Text] [Related]
34. Tacrine and lecithin in Alzheimer's disease. Patient heterogeneity explains varied response. Levy R BMJ; 1994 Jun; 308(6942):1506; author reply 1507. PubMed ID: 8019288 [No Abstract] [Full Text] [Related]
35. [Drugs for Alzheimer's disease]. Taurand P Soins; 1995 Mar; (594):61-2. PubMed ID: 7716573 [No Abstract] [Full Text] [Related]
37. Tacrine and lecithin in Alzheimer's disease. Negative conclusions not justified. Wilcock GK BMJ; 1994 Jun; 308(6942):1507. PubMed ID: 8019291 [No Abstract] [Full Text] [Related]
38. [Should Alzheimer disease be treated with tacrine? Review of the literature]. Arsland D; Laake K Tidsskr Nor Laegeforen; 1996 Sep; 116(23):2791-4. PubMed ID: 8928167 [TBL] [Abstract][Full Text] [Related]